Managers / Q3 2021 · view latest →
Wilshire Advisors LLC
CIK 0001616628 · 1299 OCEAN AVENUE, SUITE 600, SANTA MONICA, CA, 90401 · 310-451-3051
Summary
Wilshire Advisors LLC reported $38M in U.S.-listed holdings across 10 positions for Q3 2021.
The portfolio is heavily concentrated: Ishares Tr alone accounts for 21.2% of reported value.
Compared with Q2 2021, the fund opened 2 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 99.4% · $37M
- Common Stock · 0.6% · $242,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ISHARES TR | NEW | +101.9K | 101.9K | +$5M | $5M |
| FATEFATE THERAPEUTICS INC | NEW | +4.1K | 4.1K | +$242,000 | $242,000 |
| ISHARES TR | SOLD OUT | −57.3K | 0 | −$3M | $0 |
| ISHARES TR | SOLD OUT | −39.5K | 0 | −$2M | $0 |
| VANGUARD WHITEHALL FDS | TRIMMED | −10.7K | 22.3K | −$891,000 | $2M |
| ISHARES TR | TRIMMED | −7.9K | 67.4K | −$468,000 | $3M |
| ISHARES INC | ADDED | +4.6K | 88.6K | −$157,000 | $5M |
| ISHARES TR | HELD | +659 | 28.5K | −$33,000 | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ISHARES TR | CORE MSCI EAFE · CORE 1 5 YR USD · INTL TREA BD ETF · EAFE VALUE ETF · CORE S&P SCP ETF | 66.12% | $25M | 405.0K |
| 2 | ISHARES INC | CORE MSCI EMKT | 14.57% | $5M | 88.6K |
| 3 | VANGUARD CHARLOTTE FDS | TOTAL INT BD ETF | 14.01% | $5M | 92.4K |
| 4 | VANGUARD WHITEHALL FDS | EMERG MKT BD ETF | 4.65% | $2M | 22.3K |
| 5 | FATEFATE THERAPEUTICS INC | COM | 0.64% | $242,000 | 4.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $10M | 6 | May 27, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $39M | 7 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $11M | 6 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $32M | 63 | May 29, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2024 | $274M | 74 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $208M | 75 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $199M | 75 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $201M | 75 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $193M | 75 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $180M | 74 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $189M | 73 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $187M | 72 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $183M | 75 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $175M | 75 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $191M | 75 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $224M | 74 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $261M | 79 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $38M | 10 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $39M | 10 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $106M | 54 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $105M | 50 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $98M | 53 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $95M | 52 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $92M | 57 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $113M | 57 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $112M | 57 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $113M | 57 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $107M | 68 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $95M | 63 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.